1 Arqule Inc Receivables Turnover Ratio (ARQL), from the third quarter 2019 to the third quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Arqule Inc  (ARQL)
 

Arqule Inc Accounts Receivables Turnover Ratio from the third quarter 2019 to the third quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Arqule Inc's ability to collect accounts receivable sequentially worsen to 1.65, indicating more challenging environment then in the second quarter 2019, but still, it is a far cry from any concerns. Arqule Inc's Accounts Receivable average collection period in the Sep 30 2019 quarter, has increased to 221 days, from 164 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector Arqule Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Arqule Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARQL Receivables Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Receivable Change -86.35 % -54.5 % - - -
Y / Y Revenue Change -95.82 % -97.95 % -67.5 % - -
Receivable Turnover Ratio (TTM) 1.65 2.23 4.87 6.62 9.52
ARQL's Total Ranking # # # # #
Accounts Receivable average collection period days 222 164 75 55 38
Seq. Receivable Change -39.72 % -56.06 % -44.85 % -6.51 % 100.85 %
Seq. Revenue Change -25.98 % -79.11 % -54.27 % -40.93 % -63.67 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





ARQL Company Profile • Back to ARQL Efficiency Comparisons • Compare ARQL Receivables Turnover Ratio to its Competitors

Financial Statements
Arqule Inc's Accounts Receivable $ 1 Millions Visit ARQL's Balance sheet
Arqule Inc's Sales TTM $ 5 Millions Visit ARQL's Income Statement
Sources of ARQL's Revenues Visit ARQL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ARQL's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ARQL's Growth Rates ARQL's Roa ARQL's Inventory Turnover Ratio ARQL's Dividend Comparisons
ARQL's Profitability Ratios ARQL's Roi ARQL's Asset Turnover Ratio ARQL's Dividend Growth
ARQL's Valuation Ratios ARQL's Roe ARQL's Financial Strength Ratios ARQL's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Receivable at quarter ending Sep 30 2019
Seres Therapeutics Inc   15.02 $ 37.512  Millions$ 2.497  Millions
Mannkind Corporation  14.98 $ 63.076  Millions$ 4.211  Millions
Kyntra Bio Inc   14.96 $ 356.657  Millions$ 23.846  Millions
Jrsis Health Care Corp  14.77 $ 30.719  Millions$ 2.079  Millions
Ainos Inc   14.72 $ 0.015  Millions$ 0.001  Millions
Plx Pharma Inc   14.55 $ 0.829  Millions$ 0.057  Millions
Bespoke Extracts Inc  14.51 $ 0.062  Millions$ 0.004  Millions
Corcept Therapeutics Inc  14.45 $ 285.422  Millions$ 19.746  Millions
Neurometrix Inc   13.67 $ 11.294  Millions$ 0.826  Millions
Musclepharm Corporation  13.63 $ 82.413  Millions$ 6.048  Millions
Verastem Inc   13.51 $ 15.049  Millions$ 1.114  Millions
Talphera Inc   13.21 $ 2.427  Millions$ 0.184  Millions
Immucell Corporation  12.92 $ 13.028  Millions$ 1.008  Millions
Otonomy Inc   12.83 $ 0.715  Millions$ 0.056  Millions
Reflect Scientific Inc  12.57 $ 1.410  Millions$ 0.112  Millions
Parallax Health Sciences Inc   12.51 $ 0.079  Millions$ 0.006  Millions
Integrated Biopharma Inc  12.35 $ 51.079  Millions$ 4.137  Millions
Rafael Holdings Inc  12.22 $ 5.006  Millions$ 0.410  Millions
Lifeloc Technologies Inc   12.09 $ 8.715  Millions$ 0.721  Millions
Travere Therapeutics Inc   11.97 $ 172.421  Millions$ 14.399  Millions
La Jolla Pharmaceutical Company  11.95 $ 19.988  Millions$ 1.673  Millions
Zynex inc   11.84 $ 40.647  Millions$ 3.433  Millions
Ontrak Inc   11.78 $ 28.961  Millions$ 2.458  Millions
Exact Sciences Corporation  11.69 $ 723.699  Millions$ 61.882  Millions
The Pennant Group Inc   11.69 $ 88.398  Millions$ 7.562  Millions
Karyopharm Therapeutics Inc   11.61 $ 23.003  Millions$ 1.982  Millions
Rigel Pharmaceuticals Inc  11.60 $ 81.745  Millions$ 7.044  Millions
Neuronetics Inc   11.50 $ 60.935  Millions$ 5.300  Millions
Paratek Pharmaceuticals Inc   11.22 $ 24.594  Millions$ 2.192  Millions
China Pharma Holdings Inc  11.09 $ 11.118  Millions$ 1.003  Millions

Date modified: 2026-09-26T07:01:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.